-
Diagnostics World | Science and technology have moved up the appearance of a high-performance point-of-care mass spectrometer to a near-term possibility, which would make it both cheaper and more convenient to monitor chronic health conditions from just about anywhere a 3D printer could be deployed—including the jungle, Antarctica, and future colonies on Mars.
May 16, 2024
-
Diagnostics World | The lab of W. Andy Tao, professor of biochemistry at Purdue University, is pioneering a way to assess drug response based on metabolizing proteins found in circulating extracellular vesicles (EVs), which could serve as a surrogate of their expression level in the liver and become therapeutic targets for some cancers.
May 15, 2024
-
Diagnostics World | A cancer researcher at Florida International University (FIU) has developed a functional precision medicine (FPM) approach to oncology treatment decision-making that combines genomic profiling with drug sensitivity testing on patient-derived tumor cells. Children with relapsed or refractory cancers are among the initial beneficiaries.
May 14, 2024
-
Diagnostics World | Every resource in healthcare is precious. The last few years have tested healthcare systems in almost every way, with significant impacts on their long-term financial health and, by extension, the quality of care they can provide. A 2023 report by the American Hospital Association estimates that overall hospital expenses rose by 17.5% between 2019 and 2022.
May 10, 2024
-
Diagnostics World | In oncology, it is well appreciated that time is life. Diagnostics are therefore valuable not just to determine the disease state of patients but how best to treat them, says Jane Li, senior director of oncology, pharma, and CRO partnerships related to clinical sequencing at Thermo Fisher Scientific.
May 7, 2024